Status:

UNKNOWN

Cardiac Magnetic Resonance Imaging Guided Left Ventricular Lead Placement

Lead Sponsor:

Royal Brompton & Harefield NHS Foundation Trust

Conditions:

Heart Failure

Eligibility:

All Genders

18-90 years

Phase:

PHASE3

Brief Summary

Heart failure is a common, costly, disabling and potentially lethal condition. Despite well recognised and proven drug therapies, many patients remain breathless on exertion. A special pacemaker (card...

Detailed Description

Cardiac Resynchronisation Therapy (CRT) is currently recommended for patients with heart failure who have symptomatic left ventricular (LV) systolic impairment and a prolonged QRS duration.1, 2 Up to ...

Eligibility Criteria

Inclusion

  • Able to give written informed consent
  • Age \>18 years old
  • Successful CRT implantation (with or without a defibrillator)
  • NYHA Class III-IV Heart Failure (or NYHA II with NYHA III/IV symptoms in the preceding 12 months)
  • LVEF \<35% (Calculated using echocardiography or Cardiac MR) at the time of implantation
  • QRS duration \> 120ms with Left Bundle Branch Block morphology on ECG
  • Sinus Rhythm
  • Optimal Tolerated Medical Therapy for Heart Failure

Exclusion

  • Severe, life threatening non cardiac disease
  • Active malignant disease and recent (\<5 years) malignant disease
  • Prior Heart Transplant
  • Recent history of unstable angina, acute coronary syndrome or myocardial infarction within three months of enrollment into the study
  • Pregnancy
  • Failure to participate in consent process
  • Atrial Fibrillation
  • Conventional pacemaker in situ
  • Heart Failure requiring constant intravenous therapy including diuretics and/or inotropes
  • Recent revascularisation procedure i.e. coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) within the last three months
  • Contraindications to a CMR study

Key Trial Info

Start Date :

August 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2013

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT01417624

Start Date

August 1 2011

End Date

June 1 2013

Last Update

August 16 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Royal Brompton Hospital

London, London, United Kingdom, SW3 6NP